1-(5-Methyl-1H-pyrazol-3-yl)ethanone, 95.0%, 250mg

Thalidomide-PEG2-C2-NH2 (TFA), 50mg

4-Bromo-2-(4-chlorophenyl)-5-(trifluoromethyl)-1H-pyrrole-3-carbonitrile, 98%, 250mg

1-Chloro-5-fluoro-2-methoxy-4-nitrobenzene, 95.0%, 5g

2-(7-Hydroxy-4-methyl-2-oxo-2H-chromen-3-yl)acetic acid, 95.0%, 5g

L-asparagine monohydrate, min. 99%, Ph.Eur., for biochemistry, 500 g, plastic packaging.

Ethyl 5-nitrobenzo[b]furan-2-carboxylate, 95.0%, 25g

4-Methyl-1H-indole-3-carboxylic acid, 95.0%, 1g

4-(2-Pyridyl)benzaldehyde, 97.0%, 10g

Methyl (R)-2-hydroxybutanoate, 97%, 1g

5-(4-Bromophenyl)-3-methyl-1H-pyrazole, 95.0%, 5g

2-[4-(Dimethylamino)phenyl]ethanol, 95.0%, 1g

4-Bromo-6-methoxypyrimidin-2-amine, 95%, 1g